Neuronetics, Inc. (STIM)
1.52
+0.03
(+2.01%)
USD |
NASDAQ |
Apr 02, 16:00
1.54
+0.02
(+1.32%)
After-Hours: 20:00
Neuronetics Profit Margin (Quarterly) : -17.25% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| InspireMD, Inc. | -373.5% |
| Tactile Systems Technology, Inc. | 10.27% |
| Celldex Therapeutics, Inc. | -67.20K% |
| Plus Therapeutics, Inc. | -417.9% |
| Atossa Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -122.0% |
| Return on Assets | -27.77% |
| Return on Invested Capital | -33.32% |
| Gross Profit Margin (Quarterly) | 50.99% |
| Operating Margin (Quarterly) | -12.07% |
| Return on Net Operating Assets | -38.55% |